Showing results (291-300 of 5,211) with videos related to
Sort By:
Pageof 522
Journal of the American College of Cardiology|November 1, 1986
ZK 36-374, a stable analog of prostacyclin, prevents acute hypoxic pulmonary hypertension in the dogS L Archer, E Chesler, J N Cohn, et al.Pulmonary Circulation|May 11, 2013
Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertensionStephen L Archer, Yong-Hu Fang, John J Ryan, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1986
The effects of substance P on the preconstricted pulmonary vasculature of the anesthetized dogS L Archer, T J Kulik, E Chesler, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2010
Clinical significance of Staphylococcus lugdunensis isolated from routine culturesElizabeth Kleiner, Alastair B Monk, Gordon L Archer, et al.Antimicrobial Agents and Chemotherapy|June 1, 1978
Comparison of cephalothin and cefamandole prophylaxis during insertion of prosthetic heart valvesG L Archer, R E Polk, R J Duma, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|October 1, 1993
Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressureV Hampl, S L Archer, D P Nelson, et al.Clinical Genetics|September 13, 2006
Germline mosaicism for a MECP2 mutation in a man with two Rett daughtersJ C Evans, H L Archer, S D Whatley, et al.Advances in Experimental Medicine and Biology|January 10, 2004
The NO - K+ channel axis in pulmonary arterial hypertension. Activation by experimental oral therapiesEvangelos D Michelakis, M Sean McMurtry, Brian Sonnenberg, et al.Advances in Experimental Medicine and Biology|June 13, 2000
Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulationS L Archer, E K Weir, H L Reeve, et al.Biochemical and Biophysical Research Communications|August 30, 1989
Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitric oxideE G DeMaster, L Raij, S L Archer, et al.Pageof 522